Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae
about
Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.Cloning and nucleotide sequences of the topoisomerase IV parC and parE genes of Mycoplasma hominis.Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.Sparfloxacin resistance in clinical isolates of Streptococcus pneumoniae: involvement of multiple mutations in gyrA and parC genesAlterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitroFluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococciContribution of the ATP binding site of ParE to susceptibility to novobiocin and quinolones in Streptococcus pneumoniaeBiological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae.Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE lociIn vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae.Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis.Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms.Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory seBenchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States.Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model.New mutation in parE in a pneumococcal in vitro mutant resistant to fluoroquinolones.Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniaeType II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniaeDNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis.Nonmolecular test for detection of low-level resistance to fluoroquinolones in Streptococcus pneumoniae.Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance.Prevalence of first-step mutants among levofloxacin-susceptible invasive isolates of Streptococcus pneumoniae in the United StatesMechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureusPrevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in KoreaFluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children.ATP-bound conformation of topoisomerase IV: a possible target for quinolones in Streptococcus pneumoniaeAntimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.Genomic characterization of ciprofloxacin resistance in a laboratory-derived mutant and a clinical isolate of Streptococcus pneumoniae.Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolSequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained In vitro.Fluoroquinolone resistance is a poor surrogate marker for type II topoisomerase mutations in clinical isolates of Streptococcus pneumoniae.Primary targets of fluoroquinolones in Streptococcus pneumoniae.Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones.
P2860
Q24815187-9A68C3F9-0C8D-45E7-97DD-93D50B31F643Q33593776-A135E030-352E-434D-A723-6AA8C2C05D3DQ33594174-14A04CE8-43DA-4BB1-BAFB-118081852027Q33690598-FEC9ECA5-4725-4AC0-8893-233C5347B026Q33694924-9D3CE5DE-2AC3-41A3-8219-888603A8963BQ33694946-7DB2A705-00A1-4B19-AE9A-79B63B357852Q33695625-257D6598-93DA-4906-8070-285D00E7ED9DQ33696730-D6A20DE3-928E-428D-B58F-8819C805EA14Q33700561-554E76F0-D7A6-4A1C-B71D-976C03FD2FEAQ33757558-835CE86E-D23A-479E-99CC-48E90314981DQ33836664-DA0B7F7A-2A35-4192-990B-035BF199D45AQ33976037-09AA88B3-8423-4D0B-9ADB-16DE3B00FCC1Q33976055-52D4FCF9-DE12-4D19-8B15-D7E87F112E58Q33976279-454D6648-CD16-4F25-87E0-47A35D8287A8Q33976741-592FCA66-59C8-4F94-AC99-C5FD3AFF8B59Q33978324-AE12C734-A991-4AB3-A9DA-52A117298E1CQ33978849-BBB109B9-6791-4CD7-94B6-83848D0EEE97Q33980689-D3159BA5-5819-4066-9CD4-4AC7B53A886FQ33981638-D91EB3C4-5484-4445-A0E6-45AE19588858Q33981750-6940E36B-9233-47B9-89AE-F3354B3DFEA1Q33982417-D21C5F7E-8F57-45A8-B79E-B4112191E059Q33982709-FE0017D2-3033-4981-BD6A-FB74D7672668Q33983643-7356ECF3-1CFC-4283-AFE3-C4F8DB2FAFF9Q34111196-20F73C5D-C541-494E-B683-2C81CEDFBEC0Q34352053-7E7CFB56-23E9-4CB8-8AE4-FE8B09A30FB4Q34502866-EF395B8E-C77C-4893-B81A-D4533AFD7D07Q34510471-3CCEB4C3-E6C7-46BA-893F-105A1C365EACQ35139457-31B463AD-ED68-47AF-9795-7437ADB8563CQ35879084-D0F6E6DB-2B6A-472B-8CB7-393EC77F6F5FQ35880792-8E044C55-CF21-4B69-97D7-7E6D3DD56863Q36048167-CE9FC560-79DD-4885-981B-B3CE6ECD0FC7Q36423756-CF797228-3570-4ED0-B436-3EF9BF805F05Q36474350-DB1ED223-D505-4FF6-BB5B-CA435533B8F5Q37093776-4B3CBB5D-D338-49A0-81E7-CB556A745236Q37263914-BC070BC0-93C0-4C91-9844-0163A3BACECDQ37392760-114471EE-C238-43AE-B6EB-EE9C4FFF6757Q37880162-5572ED47-0BCE-4D13-ACBA-1BA1724C5EFEQ39465570-17CE8024-BFD0-4870-B923-F9F67D21610EQ39469902-7B0F9F7C-BD4C-46F9-BC2D-FBFC847B4962Q39470064-C2A25FD5-9944-405E-9D50-0D037ECB8420
P2860
Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Characterization of a mutation ...... ce in Streptococcus pneumoniae
@ast
Characterization of a mutation ...... ce in Streptococcus pneumoniae
@en
type
label
Characterization of a mutation ...... ce in Streptococcus pneumoniae
@ast
Characterization of a mutation ...... ce in Streptococcus pneumoniae
@en
prefLabel
Characterization of a mutation ...... ce in Streptococcus pneumoniae
@ast
Characterization of a mutation ...... ce in Streptococcus pneumoniae
@en
P2093
P2860
P1476
Characterization of a mutation ...... ce in Streptococcus pneumoniae
@en
P2093
Courvalin P
Perichon B
Tankovic J
P2860
P304
P407
P577
1997-05-01T00:00:00Z